Results 21 to 30 of about 12,548,139 (260)

Crosstalk between glucagon-like peptide 1 and gut microbiota in metabolic diseases

open access: yesmBio, 2023
Gut microbiota exert influence on gastrointestinal mucosal permeability, bile acid metabolism, short-chain fatty acid synthesis, dietary fiber fermentation, and farnesoid X receptor/Takeda G protein-coupled receptor 5 (TGR5) signal transduction.
Yuan Zeng   +3 more
semanticscholar   +1 more source

Phosphate Metabolism in Cardiorenal Metabolic Disease [PDF]

open access: yesCardiorenal Medicine, 2011
Hyperphosphatemia is a major risk factor for cardiovascular disease, abnormalities of mineral metabolism and bone disease, and the progression of renal insufficiency in patients with chronic renal disease. In early renal disease, serum phosphate levels are maintained within the ‘normal laboratory range’ by compensatory increases in phosphaturic ...
Deepashree, Gupta   +4 more
openaire   +2 more sources

Therapeutic Activity of Green Tea Epigallocatechin-3-Gallate on Metabolic Diseases and Non-Alcoholic Fatty Liver Diseases: The Current Updates

open access: yesNutrients, 2023
Green tea polyphenols have numerous functions including antioxidation and modulation of various cellular proteins and are thus beneficial against metabolic diseases including obesity, type 2 diabetes, cardiovascular and non-alcoholic fatty liver diseases,
Armachius James, Ke Wang, Yousheng Wang
semanticscholar   +1 more source

Eating Disorders and Metabolic Diseases

open access: yesInternational Journal of Environmental Research and Public Health, 2023
Eating disorders are complex diseases with multifactorial causes. According to the Diagnostic and Statistical Manual of Mental Disorders text version (DSM-5-TR) and the WHO International Classification of Diseases and Related Health Problems (ICD-11 ...
Zhiping Yu, Valerie Muehleman
semanticscholar   +1 more source

Enhancing intestinal barrier efficiency: A novel metabolic diseases therapy

open access: yesFrontiers in Nutrition, 2023
Physiologically, the intestinal barrier plays a crucial role in homeostasis and nutrient absorption and prevents pathogenic entry, harmful metabolites, and endotoxin absorption.
Yaoyuan Zhang   +5 more
semanticscholar   +1 more source

Therapeutic Effect of Curcumin on Metabolic Diseases: Evidence from Clinical Studies

open access: yesInternational Journal of Molecular Sciences, 2023
Metabolic diseases have become a serious threat to human health worldwide. It is crucial to look for effective drugs from natural products to treat metabolic diseases. Curcumin, a natural polyphenolic compound, is mainly obtained from the rhizomes of the
Yu-Jiao Zeng   +5 more
semanticscholar   +1 more source

Gut mycobiome and metabolic diseases: The known, the unknown, and the future.

open access: yesPharmacological Research, 2023
Metabolic diseases, such as type 2 diabetes mellitus (T2DM), non-alcoholic fatty liver disease (NAFLD) and obesity, have become a major public health problem worldwide.
Li-Jie Wang   +7 more
semanticscholar   +1 more source

The interplay between herbal medicines and gut microbiota in metabolic diseases

open access: yesFrontiers in Pharmacology, 2023
Globally, metabolic diseases are becoming a major public health problem. Herbal medicines are medicinal materials or preparations derived from plants and are widely used in the treatment of metabolic diseases due to their good curative effects and ...
Li-Jie Wang   +9 more
semanticscholar   +1 more source

Phytochemicals for the treatment of metabolic diseases: Evidence from clinical studies.

open access: yesBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2023
With the continuous improvement of people's living standard, the incidence of metabolic diseases is gradually increasing in recent years. There is growing interest in finding drugs to treat metabolic diseases from natural compounds due to their good ...
Yuting Luo   +7 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy